Ph.D. Wang Shixuan M.D.

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The levels of serum soluble interleukin-2 receptor (sIL-2R) of 36 patients with ovarian cancer, 34 with benign gynecological tumors and 31 blood donors were measured by ELISA. Compared to those of benign and normal controls, serum levels of sIL-2R in patients with ovarian cancer elevated significantly (P <0.01). Serum sIL-2R levels were likely related to(More)
  • 1